Roche and Lil­ly team up to de­vel­op blood test to de­tect ear­ly signs of Alzheimer's

Eli Lil­ly is team­ing up with Roche to help de­vel­op a blood test to de­tect ear­ly signs of Alzheimer’s dis­ease and de­ter­mine whether a pa­tient should go for fur­ther con­fir­ma­to­ry test­ing.

Roche’s Elec­sys Amy­loid Plas­ma Pan­el (EAPP) mea­sures pTau 181 pro­tein as­say and APOE E4 as­say in hu­man blood plas­ma – el­e­va­tions in pTau 181 are present in the ear­ly stages of Alzheimer’s, while the pres­ence of APO E4 is the most com­mon ge­net­ic risk fac­tor for the dis­ease.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.